Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Luca Degli Esposti, Valentina Perrone, Chiara Veronesi, Marco Gambera, Giulio Nati, Francesco Perone, Paola Fausta Tagliabue, Stefano Buda & Claudio Borghi. (2018) Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study. Current Medical Research and Opinion 34:9, pages 1571-1577.
Read now
Read now
Susanne Roas, Felix Bernhart, Michael Schwarz, Walter Kaiser & Georg Noll. (2014) Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland. International Journal of General Medicine 7, pages 549-556.
Read now
Read now
Natalie Schellack & Lucille Malan. (2014) An overview of fixed-dose combinations of antihypertensive drugs in South Africa. South African Family Practice 56:4, pages 206-211.
Read now
Read now
Krzysztof Narkiewicz. (2012) Angiotensin II receptor blocker combinations: From guidelines to clinical practice. Blood Pressure 21:2, pages 73-81.
Read now
Read now
L. Breitscheidel, B. Ehlken, K. Kostev, M. S. A. Oberdiek, A. Sandberg & R. E. Schmieder. (2012) Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. Journal of Medical Economics 15:1, pages 155-165.
Read now
Read now
Thomas Kuehlein, Gunter Laux, Andreas Gutscher, Katja Goetz, Joachim Szecsenyi, Stephen Campbell & Jost Steinhaeuser. (2011) Diuretics for hypertension – an inconsistency in primary care prescribing behaviour. Current Medical Research and Opinion 27:3, pages 497-502.
Read now
Read now
Joel M. Neutel. (2011) Long-Term Blood Pressure Control: What Can We Do?. Postgraduate Medicine 123:1, pages 88-93.
Read now
Read now
Weiyi Yang, Kristijan H. Kahler, Thomas Fellers, John Orloff, Joanne Chang, Arielle G. Bensimon, Eric Q. Wu, Chun-Po Steve Fan & Andrew P. Yu. (2011) Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy. Journal of Medical Economics 14:3, pages 267-278.
Read now
Read now
Carlos M Ferrario & Ronald D Smith. (2010) Role of olmesartan in combination therapy in blood pressure control and vascular function. Vascular Health and Risk Management 6, pages 701-709.
Read now
Read now
Joanne Chang, Weiyi Yang, Thomas Fellers, Kristijan H. Kahler, John Orloff, Jipan Xie, Magda Tsaneva, Andrew P. Yu & Eric Q. Wu. (2010) Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement. Current Medical Research and Opinion 26:9, pages 2203-2212.
Read now
Read now
Weiyi Yang, Joanne Chang, Kristijan H. Kahler, Thomas Fellers, John Orloff, Eric Q. Wu & Arielle G. Bensimon. (2010) Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Current Medical Research and Opinion 26:9, pages 2065-2076.
Read now
Read now
Christos Chatzikyrkou, Hermann Haller & Jan Menne. (2009) The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril. Expert Opinion on Pharmacotherapy 10:11, pages 1833-1840.
Read now
Read now
N. Braun, H.-J. Ulmer, A. Ansari, R. Handrock & S. Klebs. (2009) Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination. Current Medical Research and Opinion 25:2, pages 421-430.
Read now
Read now
Juha Varis, Heljä Savola, Risto Vesalainen & Ilkka Kantola. (2009) Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence‐based guidelines. Blood Pressure 18:1-2, pages 62-67.
Read now
Read now
Articles from other publishers (30)
Valeriya Nemtsova, Thilo Burkard & Annina S. Vischer. (2023) Hypertensive Heart Disease: A Narrative Review Series—Part 2: Macrostructural and Functional Abnormalities. Journal of Clinical Medicine 12:17, pages 5723.
Crossref
Crossref
Erdal Dinç, Zehra Ceren Ertekin & Eda Büker. (2023) Two-way and three-way resolutions of fluorescence excitation-emission dataset for the co-estimation of two pharmaceuticals in a binary mixture. Chemometrics and Intelligent Laboratory Systems 239, pages 104873.
Crossref
Crossref
Mende Mensa Sorato, Majid Davari, Abbas Kebriaeezadeh, Nizal Sarrafzadegan & Tamiru Shibru. (2022) Antihypertensive prescribing pattern, prescriber adherence to ISH 2020 guidelines, and implication of outpatient drug price on blood pressure control at selected hospitals in Southern Ethiopia. European Journal of Clinical Pharmacology 78:9, pages 1487-1502.
Crossref
Crossref
Fernando Perez-Ruiz & Nicola Dalbeth. (2019) Combination urate-lowering therapy in the treatment of gout: What is the evidence?. Seminars in Arthritis and Rheumatism 48:4, pages 658-668.
Crossref
Crossref
Soon Jun Hong, Han Saem Jeong, Jin-Man Cho, Kiyuk Chang, Wook Bum Pyun, Youngkeun Ahn, Min Su Hyon, Woong Chol Kang, Jae-Hwan Lee & Hyo-Soo Kim. (2019) Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial. Clinical Therapeutics 41:2, pages 233-248.e9.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2017) Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use. Drugs & Therapy Perspectives 34:1, pages 1-7.
Crossref
Crossref
Alberto Mazza, Salvatore Lenti, Laura Schiavon, Antonella Paola Sacco, Fabio Dell’Avvocata, Gianluca Rigatelli & Emilio Ramazzina. (2017) Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice. Advances in Therapy 34:4, pages 975-985.
Crossref
Crossref
G Mancia, G Cha, B Gil-Extremera, P Harvey, A J Lewin, G Villa & S E Kjeldsen. (2016) Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial. Journal of Human Hypertension 31:3, pages 178-188.
Crossref
Crossref
Peter L. Thompson. (2016) Modern Challenges in Treating Hypertension. Clinical Therapeutics 38:10, pages 2132-2134.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2016) Olmesartan medoxomil: a guide to its use as monotherapy or in fixed-dose combinations with amlodipine and/or hydrochlorothiazide. Drugs & Therapy Perspectives 32:9, pages 369-380.
Crossref
Crossref
Sverre E. Kjeldsen, Domenic Sica, Hermann Haller, Gloria Cha, Blas Gil-Extremera, Peter Harvey, Frank Heyvaert, Andrew J. Lewin, Giuseppe Villa & Giuseppe Mancia. (2014) Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile. Journal of Hypertension 32:12, pages 2488-2498.
Crossref
Crossref
Sreevalsa Unniachan, David Wu, Srinivasan Rajagopalan, Mary E. Hanson & Kenji P. Fujita. (2014) Evaluation of Blood Pressure Reduction Response and Responder Characteristics to Fixed-Dose Combination Treatment of Amlodipine and Losartan: A Post Hoc Analysis of Pooled Clinical Trials. The Journal of Clinical Hypertension 16:9, pages 671-677.
Crossref
Crossref
Hee Youn Choi, Yo Han Kim, Mi Jo Kim, Yook-Hwan Noh, Shi Hyang Lee, Kyun-Seop Bae & Hyeong-Seok Lim. (2013) Pharmacokinetics, Tolerability, and Safety of the Single Oral Administration of AGSAV301 vs Exforge: A Randomized Crossover Study of Healthy Male Volunteers. American Journal of Cardiovascular Drugs 14:1, pages 63-72.
Crossref
Crossref
Manabu Akazawa & Katsushi Fukuoka. (2013) Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis. BMC Health Services Research 13:1.
Crossref
Crossref
Henrik Lamers, Stefanie Joos, Katja Goetz, Katja Hermann, Joachim Szecsenyi & Thomas Kühlein. (2012) Diuretics for Hypertension—Reasons for a Contradiction in Primary Care Prescribing Behavior: A Qualitative Study. The Journal of Clinical Hypertension 14:10, pages 680-685.
Crossref
Crossref
Tomasz Tomasik, Adam Windak, Jacek Jozwiak, Marek Oleszczyk, Bohumil Seifert, Janko Kersnik & Elzbieta Kryj-Radziszewska. (2012) Treatment of hypertension in central and eastern European countries. Journal of Hypertension 30:8, pages 1671-1678.
Crossref
Crossref
Jennifer B. Cowart & Addison A. Taylor. (2012) Should Two-Drug Initial Therapy for Hypertension Be Recommended for All Patients?. Current Hypertension Reports 14:4, pages 324-332.
Crossref
Crossref
Samir G Mallat. (2012) What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?. Cardiovascular Diabetology 11:1, pages 32.
Crossref
Crossref
Charles D. Ciccone. 2012. Geriatric Physical Therapy. Geriatric Physical Therapy
38
63
.
&NA;. (2011) Telmisartan/amlodipine single-pill combination: a guide to its use in hypertension. Drugs & Therapy Perspectives 27:5, pages 5-9.
Crossref
Crossref
Marit D. Moen. (2010) Telmisartan/Amlodipine. American Journal Cardiovascular Drugs 10:6, pages 401-412.
Crossref
Crossref
Donald J. AbrahamColin M. Tice, Gerard M. McGeehan & David A. Claremon. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
239
266
.
T.M. Vijayakuma, G. Poovi, Thonda VSS Swaroo, G. Thirumurug & M.D. Dhanaraju. (2010) Prescribing Pattern of Fixed Dose Combinations Focus on Cardiovascular Drugs in Out Patient Department of Private Hospitals. Journal of Pharmacology and Toxicology 5:5, pages 215-221.
Crossref
Crossref
James E. Frampton & Lesley J. Scott. (2009) Amlodipine/Valsartan Single-Pill Combination. American Journal Cardiovascular Drugs 9:5, pages 309-330.
Crossref
Crossref
Theodore W Kurtz & Uwe Klein. (2009) Next generation multifunctional angiotensin receptor blockers. Hypertension Research 32:10, pages 826-834.
Crossref
Crossref
Björn Schwander, Birgit Gradl, York Zöllner, Peter Lindgren, Hans-Christoph Diener, Stephan Lüders, Joachim Schrader, Fernando Antoñanzas Villar, Wolfgang Greiner & Bengt Jönsson. (2009) Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model. Value in Health 12:6, pages 857-871.
Crossref
Crossref
Adolfo Rubinstein, Luis AlcocerAntonio Chagas. (2009) High blood pressure in Latin America: a call to action. Therapeutic Advances in Cardiovascular Disease 3:4, pages 259-285.
Crossref
Crossref
Sheila Hardy. (2009) Encouraging effective use of antihypertensives. Practice Nursing 20:7, pages 342-346.
Crossref
Crossref
Alejandro de la Sierra, Alejandro Roca-Cusachs, Josep Redón, Rafael Marín, Manuel Luque, Mariano de la Figuera, Margarida Garcia-Garcia & Liliana Falkon. (2009) Effectiveness and Tolerability of Fixed-Dose Combination Enalapril plus Nitrendipine in Hypertensive Patients. Clinical Drug Investigation 29:7, pages 459-469.
Crossref
Crossref
Brent M. Egan. (2009) Fixed-Dose Combinations and Hypertension Control in Community-Based Practices. Hypertension 53:4, pages 598-599.
Crossref
Crossref